Atlas Trials

A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled Diranersen (BIIB080) Co-administered With Diranersen in Healthy Adults

Clinical trial NCT06454721 · COMPLETED

Trial details

NCT number
NCT06454721
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteer
Start date
2025-01-30
Primary completion
2026-03-05
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.